The protocol was registered on the International Prospective Register of
Systematic Reviews database (PROSPERO) (registration number: CRD42018105465).
The search was carried out in Medline, Scopus, Web of Science, and Embase in
April 2018. Observational studies reporting patients with HLD carrying the
hexanucleotide repeat expansion in the C9orf72
gene were selected and revised; this process was carried out in duplicate. The cutoff
threshold for considering the hexanucleotide expansion as a pathogenic variant
was equal or more than 30 G4C2 repeats. The pooled frequency
and 95% CI were calculated with random effect models.